This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, J. Articles by Fagin, J. A. Search for Related Content PubMed PubMed Citation Articles by Wang, J. Articles by Fagin, J. A.

Overexpression of Insulin-Like Growth Factor-Binding Protein-4 (IGFBP-4) in Smooth Muscle Cells of Transgenic Mice through a Smooth Muscle -Actin-IGFBP-4 Fusion Gene Induces Smooth Muscle Hypoplasia

Divisions of Endocrinology and Metabolism (J.W., W.N., Y.E.N., T.L.C., J.A.F.), Pediatric Pathology (D.P.W.), Pediatric Endocrinology (S.D.C.), University of Cincinnati, Cincinnati, Ohio 45267; the Division of Cardiology, Cedars-Sinai Medical Center (B.S.), Los Angeles, California 90048; and the Department of Cell Biology, Neurobiology, and Anatomy, Ohio State University (A.R.S.), Columbus, Ohio 43210

Address all correspondence and requests for reprints to: James A. Fagin, M.D., Division of Endocrinology and Metabolism, University of Cincinnati College of Medicine, 231 Bethesda Avenue, Room 5564, Cincinnati, Ohio 45267-0547. E-mail: faginja{at}uc.edu

Insulin-like growth factor I (IGF-I) has been postulated to function as a smooth muscle cell (SMC) mitogen and to play a role in the pathogenesis of bladder hypertrophy, estrogen-induced uterine growth, and restenosis after arterial angioplasty. IGF-binding protein-4 (IGFBP-4) inhibits IGF-I action in vitro and is the most abundant IGFBP in the rodent arterial wall. To explore the function of this binding protein in vivo, transgenic mouse lines were developed harboring fusion genes consisting of a rat IGFBP-4 complementary DNA cloned downstream of either a -724 bp fragment of the mouse smooth muscle -actin 5'-flanking region (SMP2-BP-4) or -1074 bp, 63 bp of 5'-untranslated region, and 2.5 kb of intron 1 of smooth muscle -actin (SMP8-BP-4). SMP2-BP-4 mice expressed low levels of the exogenous IGFBP-4 messenger RNA (mRNA), which was not specifically targeted to SMC-rich tissue environments, and were therefore not analyzed further. Six SMP8-BP-4 transgenic lines derived from separate founders were characterized. Mating of hemizygous SMP8-BP-4 mice with controls produced about 50% transgenic offspring, with equal sex distribution. Expression of IGFBP-4 mRNA in nontransgenic littermates was maximal in liver and kidney. By contrast, transgenic IGFBP-4 mRNA expression, distinguished because of a smaller transcript size, was confined to SMC-containing tissues, with the following hierarchy: bladder > aorta > stomach = uterus. There was no transgene expression in skeletal muscle, brain, or cardiac myocytes. The abundance of IGFBP-4 measured by Western ligand blotting or by immunoblotting, was 8- to 10-fold higher in aorta and bladder of SMP8-BP-4 mice than in their nontransgenic littermates, with no change in plasma IGFBP-4 levels. Transgenic mice exhibited a significant reduction in wet weight of SMC-rich tissues, including bladder, intestine, aorta, uterus, and stomach, with no change in total body or carcass weight. In situ hybridization showed that transgene expression was targeted exclusively to the muscular layers of the arteries, veins, bladder, ureter, stomach, intestine, and uterus. Overexpression of IGFBP-4 was associated with SMC hypoplasia, a reciprocal phenotype to that of transgenic mice overexpressing IGF-I under control of the same promoter (SMP8-IGF-I). Double transgenic mice derived from mating SMP8-BP-4 with SMP8-IGF-I animals showed a modest decrease in wet weight at selected SMC tissues. Although we cannot exclude that the effects of IGFBP-4 may be IGF independent, these data suggest that IGFBP-4 is a functional antagonist of IGF-I action on SMC in vivo.

This article has been cited by other articles:

				M. Li, Y. Li, L. Lu, X. Wang, Q. Gong, and C. Duan Structural, gene expression, and functional analysis of the fugu (Takifugu rubripes) insulin-like growth factor binding protein-4 gene Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2009; 296(3): R558 - R566. [Abstract] [Full Text] [PDF]

				T. C. Nichols, W. H. Busby Jr., E. Merricks, J. Sipos, M. Rowland, K. Sitko, and D. R. Clemmons Protease-Resistant Insulin-Like Growth Factor (IGF)-Binding Protein-4 Inhibits IGF-I Actions and Neointimal Expansion in a Porcine Model of Neointimal Hyperplasia Endocrinology, October 1, 2007; 148(10): 5002 - 5010. [Abstract] [Full Text] [PDF]

				F. A. Simmen, R. Xiao, M. C. Velarde, R. D. Nicholson, M. T. Bowman, Y. Fujii-Kuriyama, S. P. Oh, and R. C. M. Simmen Dysregulation of intestinal crypt cell proliferation and villus cell migration in mice lacking Kruppel-like factor 9 Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1757 - G1769. [Abstract] [Full Text] [PDF]

				Y. Ning, A. G. P. Schuller, S. Bradshaw, P. Rotwein, T. Ludwig, J. Frystyk, and J. E. Pintar Diminished Growth and Enhanced Glucose Metabolism in Triple Knockout Mice Containing Mutations of Insulin-Like Growth Factor Binding Protein-3, -4, and -5 Mol. Endocrinol., September 1, 2006; 20(9): 2173 - 2186. [Abstract] [Full Text] [PDF]

				A. Zhang, X. Liu, J. G. Cogan, M. D. Fuerst, J. A. Polikandriotis, R. J. Kelm Jr., and A. R. Strauch YB-1 Coordinates Vascular Smooth Muscle {alpha}-Actin Gene Activation by Transforming Growth Factor {beta}1 and Thrombin during Differentiation of Human Pulmonary Myofibroblasts Mol. Biol. Cell, October 1, 2005; 16(10): 4931 - 4940. [Abstract] [Full Text] [PDF]

				J M Fleming, B J Leibowitz, D E Kerr, and W S Cohick IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells J. Endocrinol., July 1, 2005; 186(1): 165 - 178. [Abstract] [Full Text] [PDF]

				S. V. Subramanian, J. A. Polikandriotis, R. J. Kelm Jr., J. J. David, C. G. Orosz, and A. R. Strauch Induction of Vascular Smooth Muscle {alpha}-Actin Gene Transcription in Transforming Growth Factor {beta}1-Activated Myofibroblasts Mediated by Dynamic Interplay between the Pur Repressor Proteins and Sp1/Smad Coactivators Mol. Biol. Cell, October 1, 2004; 15(10): 4532 - 4543. [Abstract] [Full Text] [PDF]

				G. Yang, A. Haczku, H. Chen, V. Martin, H. Galczenski, Y. Tomer, C. R. Van Beisen, J. F. Evans, R. A. Panettieri, and C. D. Funk Transgenic smooth muscle expression of the human CysLT1 receptor induces enhanced responsiveness of murine airways to leukotriene D4 Am J Physiol Lung Cell Mol Physiol, May 1, 2004; 286(5): L992 - L1001. [Abstract] [Full Text] [PDF]

				E. Isotani, G. Zhi, K. S. Lau, J. Huang, Y. Mizuno, A. Persechini, R. Geguchadze, K. E. Kamm, and J. T. Stull Real-time evaluation of myosin light chain kinase activation in smooth muscle tissues from a transgenic calmodulin-biosensor mouse PNAS, April 20, 2004; 101(16): 6279 - 6284. [Abstract] [Full Text] [PDF]

				P. Delafontaine, Y.-H. Song, and Y. Li Expression, Regulation, and Function of IGF-1, IGF-1R, and IGF-1 Binding Proteins in Blood Vessels Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 435 - 444. [Abstract] [Full Text]

				S. Zaina, L. Pettersson, A. B. Thomsen, C.-M. Chai, Z. Qi, J. Thyberg, and J. Nilsson Shortened Life Span, Bradycardia, and Hypotension in Mice with Targeted Expression of an Igf2 Transgene in Smooth Muscle Cells Endocrinology, June 1, 2003; 144(6): 2695 - 2703. [Abstract] [Full Text] [PDF]

				S. M. Firth and R. C. Baxter Cellular Actions of the Insulin-Like Growth Factor Binding Proteins Endocr. Rev., December 1, 2002; 23(6): 824 - 854. [Abstract] [Full Text] [PDF]

				J. V. Silha and L. J. Murphy Minireview: Insights from Insulin-Like Growth Factor Binding Protein Transgenic Mice Endocrinology, October 1, 2002; 143(10): 3711 - 3714. [Abstract] [Full Text] [PDF]

				M. Zhang, E. P. Smith, H. Kuroda, W. Banach, S. D. Chernausek, and J. A. Fagin Targeted Expression of a Protease-resistant IGFBP-4 Mutant in Smooth Muscle of Transgenic Mice Results in IGFBP-4 Stabilization and Smooth Muscle Hypotrophy J. Biol. Chem., June 7, 2002; 277(24): 21285 - 21290. [Abstract] [Full Text] [PDF]

				W. A. Price, B. M. Moats-Staats, and A. D. Stiles Pro- and Anti-inflammatory Cytokines Regulate Insulin-like Growth Factor Binding Protein Production by Fetal Rat Lung Fibroblasts Am. J. Respir. Cell Mol. Biol., March 1, 2002; 26(3): 283 - 289. [Abstract] [Full Text] [PDF]

				S. Zaina, L. Pettersson, B. Ahren, L. Branen, A. B. Hassan, M. Lindholm, R. Mattsson, J. Thyberg, and J. Nilsson Insulin-like Growth Factor II Plays a Central Role in Atherosclerosis in a Mouse Model J. Biol. Chem., February 1, 2002; 277(6): 4505 - 4511. [Abstract] [Full Text] [PDF]

				C. A. Shoubridge, C.-B. Steeb, and L. C. Read IGFBP mRNA expression in small intestine of rat during postnatal development Am J Physiol Gastrointest Liver Physiol, December 1, 2001; 281(6): G1378 - G1384. [Abstract] [Full Text] [PDF]

				W. R. P. Agema, J. W. Jukema, S. N. Pimstone, and J. J. P. Kastelein Genetic aspects of restenosis after percutaneous coronary interventions;towards more tailored therapy Eur. Heart J., November 2, 2001; 22(22): 2058 - 2074. [PDF]

				E. P. Smith, A. Kamyar, W. Niu, J. Wang, B. Cercek, S. D. Chernausek, and J. A. Fagin IGF-Binding Protein-4 Expression and IGF-Binding Protein-4 Protease Activity Are Regulated Coordinately in Smooth Muscle During Postnatal Development and After Vascular Injury Endocrinology, October 1, 2001; 142(10): 4420 - 4427. [Abstract] [Full Text] [PDF]

				M. Holzenberger, G. Hamard, R. Zaoui, P. Leneuve, B. Ducos, C. Beccavin, L. Perin, and Y. Le Bouc Experimental IGF-I Receptor Deficiency Generates a Sexually Dimorphic Pattern of Organ-Specific Growth Deficits in Mice, Affecting Fat Tissue in Particular Endocrinology, October 1, 2001; 142(10): 4469 - 4478. [Abstract] [Full Text] [PDF]

				A. Bayes-Genis, R. S. Schwartz, D. A. Lewis, M. T. Overgaard, M. Christiansen, C. Oxvig, K. Ashai, D. R. Holmes Jr, and C. A. Conover Insulin-Like Growth Factor Binding Protein-4 Protease Produced by Smooth Muscle Cells Increases in the Coronary Artery After Angioplasty Arterioscler Thromb Vasc Biol, March 1, 2001; 21(3): 335 - 341. [Abstract] [Full Text] [PDF]

				M. L. Gimbel, D. Chelius, T. K. Hunt, and E. M. Spencer A Novel Approach to Reducing Postoperative Intraperitoneal Adhesions Through the Inhibition of Insulinlike Growth Factor I Activity Arch Surg, March 1, 2001; 136(3): 311 - 317. [Abstract] [Full Text] [PDF]

				G. Zhao, R. L. Sutliff, C. S. Weber, J. Wang, J. Lorenz, R. J. Paul, and J. A. Fagin Smooth Muscle-Targeted Overexpression of Insulin-Like Growth Factor I Results in Enhanced Vascular Contractility Endocrinology, February 1, 2001; 142(2): 623 - 632. [Abstract] [Full Text] [PDF]

				L. Fernandez-Celemin and J.-P. Thissen Interleukin-6 Stimulates Hepatic Insulin-Like Growth Factor Binding Protein-4 Messenger Ribonucleic Acid and Protein Endocrinology, January 1, 2001; 142(1): 241 - 248. [Abstract] [Full Text] [PDF]

				J. B. Pucilowska, K. K. McNaughton, N. K. Mohapatra, E. C. Hoyt, E. M. Zimmermann, R. B. Sartor, and P. K. Lund IGF-I and procollagen alpha 1(I) are coexpressed in a subset of mesenchymal cells in active Crohn's disease Am J Physiol Gastrointest Liver Physiol, December 1, 2000; 279(6): G1307 - G1322. [Abstract] [Full Text] [PDF]

				M. Holzenberger, P. Leneuve, G. Hamard, B. Ducos, L. Perin, M. Binoux, and Y. Le Bouc A Targeted Partial Invalidation of the Insulin-Like Growth Factor I Receptor Gene in Mice Causes a Postnatal Growth Deficit Endocrinology, July 1, 2000; 141(7): 2557 - 2566. [Abstract] [Full Text] [PDF]

				M. R. SCHNEIDER, H. LAHM, M. WU, A. HOEFLICH, and E. WOLF Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins FASEB J, April 1, 2000; 14(5): 629 - 640. [Abstract] [Full Text]

				A. Bayes-Genis, C. A. Conover, and R. S. Schwartz The Insulin-Like Growth Factor Axis : A Review of Atherosclerosis and Restenosis Circ. Res., February 4, 2000; 86(2): 125 - 130. [Abstract] [Full Text] [PDF]

				F. M. Faraci and C. D. Sigmund Vascular Biology in Genetically Altered Mice : Smaller Vessels, Bigger Insight Circ. Res., December 3, 1999; 85(12): 1214 - 1225. [Full Text] [PDF]

				J. Van Wyk Insulin-Like Growth Factors and Skeletal Growth: Possibilities for Therapeutic Interventions J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4349 - 4354. [Full Text]

				N. Miyakoshi, C. Richman, X. Qin, D. J. Baylink, and S. Mohan Effects of Recombinant Insulin-Like Growth Factor-Binding Protein-4 on Bone Formation Parameters in Mice Endocrinology, December 1, 1999; 140(12): 5719 - 5728. [Abstract] [Full Text]

				T. C. Nichols, T. d. Laney, B. Zheng, D. A. Bellinger, G. A. Nickols, W. Engleman, and D. R. Clemmons Reduction in Atherosclerotic Lesion Size in Pigs by {alpha}V{beta}3 Inhibitors Is Associated With Inhibition of Insulin-Like Growth Factor-I-Mediated Signaling Circ. Res., November 26, 1999; 85(11): 1040 - 1045. [Abstract] [Full Text] [PDF]

				D. R. Clemmons, G. Horvitz, W. Engleman, T. Nichols, A. Moralez, and G. A. Nickols Synthetic {alpha}V{beta}3 Antagonists Inhibit Insulin-Like Growth Factor-I-Stimulated Smooth Muscle Cell Migration and Replication Endocrinology, October 1, 1999; 140(10): 4616 - 4621. [Abstract] [Full Text]

				K. Wallner, C. Li, M. C. Fishbein, P. K. Shah, and B. G. Sharifi Arterialization of human vein grafts is associated with tenascin-C expression J. Am. Coll. Cardiol., September 1, 1999; 34(3): 871 - 875. [Abstract] [Full Text] [PDF]

				T. Gustafsson, P. Andersson, Y. Chen, J. O. Magnusson, and H. J. Arnqvist Interaction of angiotensin II and the insulin-like growth factor system in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H499 - H507. [Abstract] [Full Text] [PDF]

				S. Maeda, R. L. Sutliff, J. Qian, J. N. Lorenz, J. Wang, H. Tang, T. Nakayama, C. Weber, D. Witte, A. R. Strauch, et al. Targeted Overexpression of Parathyroid Hormone-Related Protein (PTHrP) to Vascular Smooth Muscle in Transgenic Mice Lowers Blood Pressure and Alters Vascular Contractility Endocrinology, April 1, 1999; 140(4): 1815 - 1825. [Abstract] [Full Text]

				C. Rees, D. R. Clemmons, G. D. Horvitz, J. B. Clarke, and W. H. Busby A Protease-Resistant Form of Insulin-Like Growth Factor (IGF) Binding Protein 4 Inhibits IGF-1 Actions Endocrinology, October 1, 1998; 139(10): 4182 - 4188. [Abstract] [Full Text] [PDF]

				Z.-H. Yang, Y. Kitami, Y. Takata, T. Okura, and K. Hiwada Targeted Overexpression of CCAAT/Enhancer-Binding Protein-{delta} Evokes Enhanced Gene Transcription of Platelet-Derived Growth Factor {alpha}-Receptor in Vascular Smooth Muscle Cells Circ. Res., September 14, 2001; 89(6): 503 - 508. [Abstract] [Full Text] [PDF]